The Association of Hypovitaminosis D with the Metabolic Syndrome is Independent of the Degree of Obesity

Overview

Journal ISRN Endocrinol

Specialty Endocrinology

Date 2012 Nov 15

PMID 23150833

Citations 17

Authors

Inka Minambres

Joan Sanchez-Hernandez

Jose Luis Sanchez-Quesada

Jose Rodriguez

Alberto DE Leiva

Antonio Perez

Affiliations

Soon will be listed here.

Abstract

Background. It remains uncertain whether the metabolic syndrome (MS) or insulin resistance contribute to the association between vitamin D deficiency and obesity. Methods. We conducted a cross-sectional survey of 343 subjects who were overweight or obese. We analyzed anthropometric data and the presence or absence of MS. Additionally, we determined 25-hydroxyvitamin D (25OHD) and insulin concentrations, and the HOMA index was calculated. Chi-square test,Mann-Whitney U test, Student's t-tests,and logistic regression analysis were used. Results. The mean age of the patients was 42 ± 11 years, and 65.9% were women. The mean BMI was 34.7 ± 8.3 kg/m(2) and 25(OH)D levels were 53.7 ± 29.8 nmol/L. Forty-six patients (13.4%) had MS. Vitamin D status was associated with the degree of obesity, especially with a BMI > 40 kg/m(2). Patients with MS had lower levels of 25(OH)D than patients without (43.3 ± 29.0 versus 55.3 ± 29.6 mmol/L, resp.), and the odds ratio for hypovitaminosis D was 2.7 (confidence interval (CI), 1.14-6.4) (P = .023) for patients with MS versus patients without MS, irrespective of the degree of obesity. Conclusions. Our data confirm the association between vitamin D and MS and suggest that this association is independent of the degree of obesity.

Citing Articles

The association between obesity and vitamin D deficiency modifies the progression of kidney disease after ischemia/reperfusion injury.

Bernardo D, Canale D, Nascimento M, Shimizu M, Seguro A, de Braganca A Front Nutr. 2022; 9:952028.

PMID: 36466412 PMC: 9713235. DOI: 10.3389/fnut.2022.952028.

Serum and Dietary Vitamin D in Individuals with Class II and III Obesity: Prevalence and Association with Metabolic Syndrome.

Silveira E, de Souza Cardoso C, Moura L, Rodrigues A, de Oliveira C Nutrients. 2021; 13(7).

PMID: 34206539 PMC: 8308482. DOI: 10.3390/nu13072138.

Association of Serum 25-Hydroxyvitamin D Level With Metabolic Phenotypes of Obesity in Children and Adolescents: The CASPIAN-V Study.

Esmaili H, Heshmat R, Ejtahed H, Rastad H, Motlagh M, Asayesh H Front Endocrinol (Lausanne). 2020; 11:310.

PMID: 32612573 PMC: 7308554. DOI: 10.3389/fendo.2020.00310.

A prospective, cross-sectional study on association of serum vitamin D level with musculoskeletal symptoms and blood pressure in adult population.

Singh V, Misra A, Singh M, Kumar B, Midha N, Ambwani S J Family Med Prim Care. 2020; 9(3):1628-1632.

PMID: 32509663 PMC: 7266254. DOI: 10.4103/jfmpc.jfmpc_872_19.

CORRELATIONS OF SERUM VITAMIN D WITH METABOLIC PARAMETERS IN ADULT OUTPATIENTS WITH DIFFERENT DEGREES OF OVERWEIGHT / OBESITY COMING FROM AN URBAN COMMUNITY.

Nikolova M, Boyanov M, Tsakova A Acta Endocrinol (Buchar). 2019; 14(3):375-383.

PMID: 31149286 PMC: 6525776. DOI: 10.4183/aeb.2018.375.

References

Hypponen E, Boucher B, Berry D, Power C . 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2007; 57(2):298-305. DOI: 10.2337/db07-1122. View

Brodie M, Boobis A, Hillyard C, Abeyasekera G, Stevenson J, MacIntyre I . Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther. 1982; 32(4):525-30. DOI: 10.1038/clpt.1982.197. View

Muldowney S, Lucey A, Paschos G, Martinez J, Bandarra N, Thorsdottir I . Relationships between vitamin D status and cardio-metabolic risk factors in young European adults. Ann Nutr Metab. 2011; 58(2):85-93. DOI: 10.1159/000324600. View

Vacek J, Vanga S, Good M, Lai S, Lakkireddy D, Howard P . Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol. 2011; 109(3):359-63. DOI: 10.1016/j.amjcard.2011.09.020. View

Winters S, Chennubhatla R, Wang C, Miller J . Influence of obesity on vitamin D-binding protein and 25-hydroxy vitamin D levels in African American and white women. Metabolism. 2009; 58(4):438-42. DOI: 10.1016/j.metabol.2008.10.017. View

Wortsman J, Matsuoka L, Chen T, Lu Z, Holick M . Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000; 72(3):690-3. DOI: 10.1093/ajcn/72.3.690. View

Reis J, von Muhlen D, Miller 3rd E, Michos E, Appel L . Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics. 2009; 124(3):e371-9. PMC: 4222068. DOI: 10.1542/peds.2009-0213. View

Holick M . Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. DOI: 10.1056/NEJMra070553. View

Ganji V, Zhang X, Shaikh N, Tangpricha V . Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006. Am J Clin Nutr. 2011; 94(1):225-33. DOI: 10.3945/ajcn.111.013516. View

10.

Lee D, Rutter M, ONeill T, Boonen S, Vanderschueren D, Bouillon R . Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. Eur J Endocrinol. 2009; 161(6):947-54. DOI: 10.1530/EJE-09-0496. View

11.

Pacifico L, Anania C, Osborn J, Ferraro F, Bonci E, Olivero E . Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol. 2011; 165(4):603-11. DOI: 10.1530/EJE-11-0545. View

12.

Alvarez J, Ashraf A . Role of vitamin d in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2009; 2010:351385. PMC: 2778451. DOI: 10.1155/2010/351385. View

13.

Ford E, Ajani U, McGuire L, Liu S . Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005; 28(5):1228-30. DOI: 10.2337/diacare.28.5.1228. View

14.

Gulseth H, Gjelstad I, Tierney A, Lovegrove J, Defoort C, Blaak E . Serum vitamin D concentration does not predict insulin action or secretion in European subjects with the metabolic syndrome. Diabetes Care. 2010; 33(4):923-5. PMC: 2845053. DOI: 10.2337/dc09-1692. View

15.

Kamycheva E, Sundsfjord J, Jorde R . Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study. Eur J Endocrinol. 2004; 151(2):167-72. DOI: 10.1530/eje.0.1510167. View

16.

Malnick S, Knobler H . The medical complications of obesity. QJM. 2006; 99(9):565-79. DOI: 10.1093/qjmed/hcl085. View

17.

Deluca H . Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004; 80(6 Suppl):1689S-96S. DOI: 10.1093/ajcn/80.6.1689S. View

18.

Chacko S, Song Y, Manson J, Van Horn L, Eaton C, Martin L . Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr. 2011; 94(1):209-17. PMC: 3127524. DOI: 10.3945/ajcn.110.010272. View

19.

Reis J, von Muhlen D, Miller 3rd E . Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol. 2008; 159(1):41-8. DOI: 10.1530/EJE-08-0072. View

20.

Hahn T . Drug-induced disorders of vitamin D and mineral metabolism. Clin Endocrinol Metab. 1980; 9(1):107-27. DOI: 10.1016/s0300-595x(80)80023-5. View